Showing results (141-150 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|April 22, 2008
Identification of CYP2D6 null variants among long-stay, chronic psychiatric inpatients: is it strictly necessary?Ana Fernández-Santander, Catalina Santiago, Sarai Díez-Durán, et al.Human Psychopharmacology|August 24, 2019
Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment optionsMathew Chiang, Domenico Lombardi, Jiang Du, et al.Human Psychopharmacology|May 27, 2015
No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese populationHidehiro Umehara, Shusuke Numata, Atsushi Tajima, et al.Human Psychopharmacology|April 23, 2015
Persistent benefits of slow titration of paroxetine in a six-month follow-upPaolo Olgiati, Alessandro SerrettiHuman Psychopharmacology|May 1, 2020
Drug-induced tics: An observational postmarketing studyDavy Touafchia, François Montastruc, Maryse Lapeyre-Mestre, et al.Human Psychopharmacology|July 22, 2015
Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDDChristine Jackson, Brenda Pearson, Susan Girdler, et al.Human Psychopharmacology|August 19, 2003
Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depressionShigeru Morishita, Seizaburo AritaHuman Psychopharmacology|August 19, 2003
Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in JapanToshiya Inada, Shoko Nozaki, Ataru Inagaki, et al.Human Psychopharmacology|August 19, 2003
Changes in urinary monoamine excretion in hyperkinetic childrenMarat G Uzbekov, Eduard Y MisionzhnikHuman Psychopharmacology|April 3, 2003
Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?Jae-Min Kim, Declan Lyons, Il-Seon Shin, et al.Pageof 148